"Pacific Hematology Oncology Associates: *Dr. Ari Baron *Dr. Kathleen Grant *Dr. Kevin Knopf *Dr. Betrand Tuan; Lang:We Use Interpreters"

During the past decade, Pacific Hematology Oncology Associates conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 17 clinical trials were completed, i.e. on average, 141.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 11 clinical trials were completed. i.e. 1100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pacific Hematology Oncology Associates" #1 sponsor was "Bristol-Myers Squibb" with 6 trials, followed by "Seagen Inc." with 3 trials sponsored, "Clovis Oncology, Inc." with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Halozyme Therapeutics" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Hematology Oncology Associates" #1 collaborator was "Foundation Medicine" with 2 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Hematology Oncology Associates" are "Prostate Cancer" (5 trials), "Colorectal Cancer" (2 trials), "Metastatic Castration Resistant Prostate Cancer" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Adenocarcinoma of the Lung" (1 trials). Many other conditions were trialed in "Pacific Hematology Oncology Associates" in a lesser frequency.

Most popular intervention types in "Pacific Hematology Oncology Associates" are "Drug" (30 trials), "Biological" (5 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Gemcitabine" (3 trials), "Nivolumab" (3 trials), "Abiraterone" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Hematology Oncology Associates" are 21 trials for "All" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Pacific Hematology Oncology Associates". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Pacific Hematology Oncology Associates, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Hematology Oncology Associates, 4 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".